Caliway Biopharmaceuticals (6919 TT)

Analysis

Health Care • Taiwan

Caliway Biopharmaceuticals Co., Ltd. focuses on breakthrough medical aesthetics and inflammatory medicine discovery of small molecule therapeutics. The Company develops CBL-514 to treat subcutaneous fat. Caliway Biopharmaceuticals conducts businesses across worldwide.

Refresh

Company Presentation • 29 Sep 2026 10:00

Investor presentation

Company Presentation • 29 Sep 2026 14:00

Caliway Biopharmaceuticals Co., Ltd.

Company Presentation • 31 Aug 2026 10:00

Investor presentation

Company Presentation • 31 Aug 2026 14:00

Caliway Biopharmaceuticals Co., Ltd.

Company Presentation • 26 May 2026 10:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00